LILLI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 1.343
EU - Europa 443
AS - Asia 182
AF - Africa 48
SA - Sud America 18
Totale 2.034
Nazione #
US - Stati Uniti d'America 1.335
UA - Ucraina 112
IN - India 111
SE - Svezia 97
DE - Germania 68
IT - Italia 57
FI - Finlandia 56
TG - Togo 43
CN - Cina 40
SG - Singapore 26
AR - Argentina 18
BG - Bulgaria 12
IE - Irlanda 9
GB - Regno Unito 8
BE - Belgio 7
CA - Canada 6
CH - Svizzera 6
RU - Federazione Russa 5
TR - Turchia 4
NL - Olanda 3
BJ - Benin 2
ZA - Sudafrica 2
BZ - Belize 1
IR - Iran 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
PT - Portogallo 1
RO - Romania 1
Totale 2.034
Città #
Fairfield 168
Chandler 141
Ann Arbor 99
Woodbridge 97
Ashburn 90
Seattle 59
Princeton 58
Wilmington 57
Plano 54
Boston 50
Houston 48
Cambridge 43
Lomé 43
Jacksonville 42
Beijing 28
Des Moines 19
Lawrence 19
Federal 18
Rome 17
San Diego 17
San Paolo di Civitate 17
Dearborn 16
Sofia 12
Dublin 9
New York 9
Singapore 9
Andover 8
Boardman 7
Brussels 7
Bühl 7
Grafing 6
Millbury 6
Toronto 6
Bern 5
Falls Church 5
Norwalk 5
San Jose 5
Washington 5
Helsinki 4
Istanbul 4
Nanjing 3
San Mateo 3
Auburn Hills 2
Bremen 2
Buffalo 2
Dallas 2
Fasano 2
Frankfurt am Main 2
Los Angeles 2
Simi Valley 2
Amsterdam 1
Atlanta 1
Baotou 1
Belize City 1
Berlin 1
Busalla 1
Changsha 1
Chisinau 1
Cremona 1
Cusano Milanino 1
Fremont 1
Guangzhou 1
Hefei 1
Jinan 1
Latina Scalo 1
Laurel 1
London 1
Malo 1
Mexico City 1
Muizenberg 1
Mumbai 1
Munich 1
Perugia 1
Piacenza 1
Pune 1
Redmond 1
Saint Louis 1
Shenyang 1
Silverton 1
St Louis 1
Taizhou 1
Teramo 1
Trumbull 1
Villafranca 1
Zhengzhou 1
Zurich 1
Totale 1.377
Nome #
Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis 98
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation 78
A novel class of selective anti-Helicobacter pylori agents 2-Oxo-2H-chromene-3-carboxamide derivatives. 78
HCV\HGV coinfection and cryoglobulinemia. 75
Diagnostic value of anti-hepatitis C virus (HCV) core immunoglobulin M in recurrence of HCV infection after orthotopic liver transplantation 73
Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides 70
Aspetti epidemiologici delle complicanze infettive Problemi Microbiologici chemoterapici e immunologici nel paziente ad alto rischio 67
Occult hepatitis C virus infection in type II mixed cryoglobulinaemia 65
Synthesis and In Vitro Selective anti-Helicobacter pylori Activity of Pyrazoline Derivatives 65
Prevalence of TT virus infection in Italian-dialysis patients 63
Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp. 59
Studio della distribuzione dei genotipi in casi di epatopatia HCV-correlata 56
HCV\HGV coinfection and cryoglobulinemia 56
Linfomi non- Hodgkin AIDS-relati (LNH-AIDS) e confezione da virus dell’epatite C (HCV) 55
Use of Oligoprobes on Amplified DNA in the Diagnosis of Bacterial Meningitis 55
Porphyria cutanea tarda and hepatitis G and C virus infection 50
Dual infection with hepatitis G virus (HGV) and hepatitis C virus (HCV) in relation to different HCV genotypes 46
Polymerase Chain Reaction, with sequencing, as a diagnostic tool in culture-negative bacterial meningitis 46
IgM anti-hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication 46
Effect of excess alcohol intake on HCV replication in chronic alcoholics. A pilot study. 43
Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents 41
Ruolo delle interazioni tra il virus di Epstein Barr e la matrice nucleare nelle neoplasie EBV-associate 39
Role of viral hepatitis infection in Italian patients with sporadic and familial porphyria cutanea tarda 38
Studio epidemiologico su pazienti sottoposti a trapianto d'organo 38
Different reactivity against HCV proteins (RIBA 3) according to progression of liver damage 36
Evauation of indeterminate sera for the Hepatitis C virus by assay using syntetic peptides 34
HEPATITIS C AND ALCOHOL : EPIDEMIOLOGY IN ITALY 33
Differente reattività verso le proteine di HCV in paziente con danno epatico da HCV. 33
Rapporto tra nuovi farmaci immunosoppressori e infezioni virali 32
Analisi di sieri indeterminati al test Riba di II generazione mediante test con antigeni proteici di sintesi 32
Ig m anti-HCV and polymerase chain reaction in chronic hcv hepatitis 28
Detection of antibody to hepatitis C Virus in dialysis patients. 28
HCV-GENOTIPI. VARIAZIONE NELL'EPIDEMIOLOGIA 27
Detectionof HBV DNA in serum by two quantitative tecniques. 27
Identificazione dell'HCV-RNA confronto tra nested-PCR e single step PCR 26
Genotypes identification in HCV positive patients 26
HCVRNA and HCV genotypes in chronic HCV hepatitis relapsed after interferon therapy. 26
Hepatitis C virus in patients with porphyria cutanea tarda:relationship to genotypes 24
HCV recurrence in liver transplantation study of anti-HCv IgM and HCV-RNA 23
Use of ELISA with TTvirus (TTV) to detect anti TTV antibodies in human sera 23
Il fattore reumatoide come causa di false positività nella diagnostica sierologica degli immunodepressi 22
Distribution of the HCV genotypes in PCT: comparison with HCV-related chronic liver disease 21
Test di sensibilita’ agli antibiotici per aerobi ed anaerobi nella pratica clinica. 21
Recurrence of hepatitis C virus infection after orthotopic liver transplantation: role of genotypes 21
Sensitivity tests to antibiotics for aerobes and anaerobes in clinical practice 19
Follow-up di pazienti sottoposti a trapianto di rene. 18
Studio degli anticorpi anti-HCV :Follow-up in emodializzati e trapiantati di rene . 16
Hepatitis C virus in patients with porphyria cutanea tarda. 15
Studio dell'incidenza dell'HCV,TTV,in pazienti con PCT di origine ereditaria e sporadica. 15
Ricerca degli anticorpi anti-HCV e correlazione con i markers dell'epatite B in una popolazione a rischio 13
PAZIENTE IMMUNOCOMPROMESSO:STUDIO MICROBIOLOGICO IN VITRO DI NUOVE MOLECOLE NEI CONFRONTI DI ISOLATI CLINICI 13
Porphyria cutanea tarda and hepatitis C and G virus infections: Study in a Center-South Italy population. 12
Ruolo della matrice nucleare nelle neoplasie associate alla infezione da virus di Epstein Barr", 11
Totale 2.075
Categoria #
all - tutte 5.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019107 0 0 0 0 0 0 0 0 0 0 65 42
2019/2020415 73 12 5 19 30 62 41 44 37 56 28 8
2020/2021151 20 18 6 15 6 10 0 19 11 25 16 5
2021/2022473 3 31 41 15 64 3 7 49 46 41 66 107
2022/2023522 98 94 32 53 64 64 4 22 55 18 16 2
2023/2024154 16 36 6 12 14 29 0 4 0 29 8 0
Totale 2.075